Capkun V - Search Results

1

Retrospective analysis of efficacy of trastuzumab in adjuvant treatment of HER 2 positive early breast cancer - single institution experience.

Ban M, Viculin J, Tomic S, Capkun V, Strikic A, Mise BP, Utrobicic I, Vrdoljak E. Ban M, et al. Among authors: capkun v. Neoplasma. 2016;63(5):761-7. doi: 10.4149/neo_2016_513. Neoplasma. 2016. PMID: 27468880

2

Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer.

Miše BP, Telesmanić VD, Tomić S, Šundov D, Čapkun V, Vrdoljak E. Miše BP, et al. Among authors: capkun v. Pathol Oncol Res. 2015 Apr;21(2):347-56. doi: 10.1007/s12253-014-9827-1. Epub 2014 Aug 11. Pathol Oncol Res. 2015. PMID: 25108408 Free article.

3

Expression of topoisomerase II-α in triple negative breast cancer.

Mrklić I, Pogorelić Z, Ćapkun V, Tomić S. Mrklić I, et al. Among authors: capkun v. Appl Immunohistochem Mol Morphol. 2014 Mar;22(3):182-7. doi: 10.1097/PAI.0b013e3182910967. Appl Immunohistochem Mol Morphol. 2014. PMID: 23702653

4

Expression of androgen receptors in triple negative breast carcinomas.

Mrklić I, Pogorelić Z, Capkun V, Tomić S. Mrklić I, et al. Among authors: capkun v. Acta Histochem. 2013 May;115(4):344-8. doi: 10.1016/j.acthis.2012.09.006. Epub 2012 Sep 29. Acta Histochem. 2013. PMID: 23031358

5

Prognostic value of Ki-67 proliferating index in triple negative breast carcinomas.

Mrklić I, Ćapkun V, Pogorelić Z, Tomić S. Mrklić I, et al. Among authors: capkun v. Pathol Res Pract. 2013 May;209(5):296-301. doi: 10.1016/j.prp.2013.02.012. Epub 2013 Mar 15. Pathol Res Pract. 2013. PMID: 23601837

6

The role of nm23 gene in colorectal carcinogenesis.

Tripković A, Tripković I, Tomić S, Kovacić A, Grandić L, Capkun V. Tripković A, et al. Among authors: capkun v. Acta Clin Croat. 2012 Mar;51(1):43-9. Acta Clin Croat. 2012. PMID: 22920000

7

P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas.

Sundov D, Caric A, Mrklic I, Gugic D, Capkun V, Hofman ID, Mise BP, Tomic S. Sundov D, et al. Among authors: capkun v. Diagn Pathol. 2013 Feb 6;8:21. doi: 10.1186/1746-1596-8-21. Diagn Pathol. 2013. PMID: 23388101 Free PMC article.

8

Prognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer.

Čeprnja T, Mrklić I, Perić Balja M, Marušić Z, Blažićević V, Spagnoli GC, Juretić A, Čapkun V, Tečić Vuger A, Vrdoljak E, Tomić S. Čeprnja T, et al. Among authors: capkun v. J Pers Med. 2022 Jun 8;12(6):941. doi: 10.3390/jpm12060941. J Pers Med. 2022. PMID: 35743725 Free PMC article.

9

Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.

Bezić J, Samija-Projić I, Projić P, Ljubković J, Capkun V, Tomić S. Bezić J, et al. Among authors: capkun v. Pathol Res Pract. 2011 Jul 15;207(7):438-42. doi: 10.1016/j.prp.2011.04.005. Epub 2011 Jun 20. Pathol Res Pract. 2011. PMID: 21689895

10

Prognostic value of MVD, LVD and vascular invasion in lymph node-negative colon cancer.

Sundov Z, Tomic S, Alfirevic S, Sundov A, Capkun V, Nincevic Z, Nincevic J, Kunac N, Kontic M, Poljak N, Druzijanic N. Sundov Z, et al. Among authors: capkun v. Hepatogastroenterology. 2013 May;60(123):432-8. doi: 10.5754/hge12826. Hepatogastroenterology. 2013. PMID: 23321007

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters